Monique K. Mansoura | Executive Director, Global Health Security & Biotechnology
Independent
From 2002-2011, she led strategic policy, planning and budgeting for a pioneering multibillion-dollar medical countermeasures development and acquisition program in the U.S. Department of Health and Human Services under the authorities of the Project BioShield Act of 2004 and the Pandemic and All-Hazards Preparedness Act of 2006. From 2012-2016, she was the leader of a Global Program Team at Novartis Vaccines (Seqirus, A CSL Company, after the July 2015 acquisition) including a role as Head, Medical Countermeasures and Government Affairs. Americas.
During a recent sabbatical, Monique examined innovative financing approaches in healthcare as a Research Affiliate of the MIT Laboratory for Financial Engineering (LFE), Sloan School of Management. She led an LFE healthcare finance initiative with Professor Andrew Lo that explored new business models and financial vehicles for raising and deploying funds to enhance global health security. She is a member of the Council on Foreign Relations.
Appearances:
Pre-Congress Workshops - 21st April @ 10:00
BIODEFENSE
Protecting public health from biothreats to pandemics.
- What is the progress on new technologies in medical product development?
- How our governments are incentivizing (portfolio approach), especially with biotech and industry? What International collaborations are being facilitated?
How our governments are incentivizing (portfolio approach), especially with biotech and industry?
10:10 Melinda Hamer, Operating Partner, GHIC
10:30 BARDA & Sabin: Kelly Warfield, Sabin Vaccine Institute’s President of Research & Development, Sabin Institute
10:50 – 11:50 Panel: Collaboration with industry: the solution for a sustainable posture for biodefence and global health security
Col Matt Clark, Joint Project Manager, CBRN, JPEO-CBRND
Kevin Webb, COO, API Innovation Center
Chan Harjivan, Former Assistant at The White House & Chief Strategy Officer, The Medical Countermeasures Coalition
11:50 – 12:50 Panel: Rapid vaccine development through manufacturing innovation
Moderator: Praneel Jadav, Manager, Infectious Disease Policy, BIO
Mike Stebbins, Manufacturing and Threat Countermeasures Division, ATI
Renee Hart, President & CBO, LumaCyte
Lakshmi Krishnan, Vice President of Research, National Research Council of Canada
1:00 - 2:00 break
2:00 – 3:10 Panel: What are the remaining bottlenecks holding us back from achieving the 100 day mission?
Moderator: Dr Philip Krause, Independent Consultant & Former FDA
William Falstich, VP, Primary Care Category Supply Chain Lead, Pfizer
Dr Bassam Hallis, Deputy Director, Vaccine Development & Evaluation Centre, UKHSA
Dr Seth Berkley, Former CEO, Gavi; Senior Advisor, Pandemic Center at Brown University
Marion Gruber, Vice President, Public Health and Regulatory Affairs, IAVI
Kent Kester, Executive Director, Vaccine Research and Development, CEPI
3:10 – 4:10 Panel: International pandemic funding – how can we make it accessible globally?
Moderator: Soazic Elise Wang Sonn, Economist, World Bank Group, Washington D.C.
Dr Seth Berkley, Former CEO, Gavi; Senior Advisor, Pandemic Center at Brown University
Dr Christian Tientcha Happi, Professor of Molecular Biology and Genomics in the Department of Biological Sciences & Director, African Center of Excellence for Genomics of Infectious Diseases (ACEGID)
Megan Rauscher, Senior Manager, Private Sector Program Lead, ThinkWell
Dr Monique K Mansoura, Executive Director, Global Health Security & Biotechnology, Independent
Main Congress Day 2 - 23rd April @ 09:40
Panel: Ensuring equitable vaccine distribution during outbreaks, epidemics and pandemics
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events